4-(4-(tert-Butoxycarbonyl)piperazine-1 -carbonyl)-3-fluorophenylboronic acid
98%
Reagent
Code: #90419
CAS Number
1704069-67-9
blur_circular Chemical Specifications
scatter_plot
Molecular Information
Weight
352.166 g/mol
Formula
C₁₆H₂₂BFN₂O₅
inventory_2
Storage & Handling
Storage
room temperature, dry
description Product Description
This chemical is primarily utilized in organic synthesis, particularly in the development of pharmaceuticals and biologically active compounds. It serves as a key intermediate in the preparation of complex molecules, often in the context of Suzuki-Miyaura cross-coupling reactions, which are widely used to form carbon-carbon bonds. The presence of the boronic acid group makes it a valuable reagent for coupling with aryl halides, enabling the synthesis of biaryl structures commonly found in drug molecules. Additionally, the tert-butoxycarbonyl (Boc) protecting group on the piperazine moiety allows for selective deprotection, facilitating further functionalization in multi-step synthetic pathways. Its application is particularly relevant in the synthesis of targeted therapies, including kinase inhibitors and other small-molecule drugs.
shopping_cart Available Sizes & Pricing
4-(4-(tert-Butoxycarbonyl)piperazine-1 -carbonyl)-3-fluorophenylboronic acid
This chemical is primarily utilized in organic synthesis, particularly in the development of pharmaceuticals and biologically active compounds. It serves as a key intermediate in the preparation of complex molecules, often in the context of Suzuki-Miyaura cross-coupling reactions, which are widely used to form carbon-carbon bonds. The presence of the boronic acid group makes it a valuable reagent for coupling with aryl halides, enabling the synthesis of biaryl structures commonly found in drug molecules. Additionally, the tert-butoxycarbonyl (Boc) protecting group on the piperazine moiety allows for selective deprotection, facilitating further functionalization in multi-step synthetic pathways. Its application is particularly relevant in the synthesis of targeted therapies, including kinase inhibitors and other small-molecule drugs.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
Total
$0.00
AUD